Bridgehead Communications
Lifebit logo

Lifebit

Genomics and real-world data platform

Health data & AI platforms

London-based federated genomics and real-world data platform that lets pharma R&D teams analyse sensitive datasets in place, without moving the underlying data.

The read

Lifebit operates a federated Trusted Research Environment that lets pharma, biotech and government health bodies analyse sensitive genomic and multi-omic data in place, rather than centralising it, aimed at speeding up drug target validation and biomarker discovery.

Its Genomics England relationship and long-term Boehringer Ingelheim AI partnership are among its most independently corroborated deployments, alongside government-scale work with Singapore's national health data agency Synapxe.

The Bridgehead view

Lifebit's federated-analysis pitch, letting pharma R&D touch data it's not allowed to move, solves a real procurement blocker rather than a nice-to-have, which is why its pharma partnerships have stuck longer than most funding-round headlines in this category.

FAQs

About this page

No. The MedTech Index is independent editorial coverage — we track and write up companies we judge genuinely significant in the sector, and inclusion is not for sale. Where shown, coverage of Lifebit above is drawn from public reporting, not sponsored content.

We map the sector by who is actually shaping it: funding, product reach, regulatory engagement and the coverage they earn. The MedTech Index is maintained by our editorial team and updated as the market moves, not compiled from vendor submissions.

Yes. If you represent Lifebit, or anything here looks out of date, get in touch through our contact page and we will review it.

Work with us

Building a medtech brand?

We run PR and public affairs for companies in this market: from category launches and funding announcements to NHS procurement and regulatory communications.

Working across the healthcare sector?

We advise NHS-facing organisations, providers and health systems on reputation, policy engagement and communications that understand the sector.

The firm that knows medtech

We map this sector because
we represent it.

Whether you build medical technology or run the health systems that buy it, we know the market, the media and the regulatory landscape it operates in. Thirty minutes with a partner tells you if we can help.